Abstract
Objective: The aim of present study is to develop and explore efficiency of 5.0G EDA PAMAM dendrimers as long-duration drug release carriers for the treatment of tuberculosis.
Method: Rifampicin (RIF) was selected as a major drug for incorporation into PAMAM dendrimers based on its anti-tubercular activity and hydrophobic nature. Further polyethylene glycol (PEGylated) PAMAM dendrimers were evaluated for their hemolytic toxicity and in vivo anti-tubercular studies. The 5.0G PAMAM dendrimers are prepared by using initiator core ethylene diamine and methyl acrylate. Furthermore, the PEGylation was done by polyethylene glycol 2000 using epichlorhydrin as a cross linking agent.
Result: The Rifampicin loaded PEGylated 5.0G PAMAM dendrimers were characterized by FTIR, NMR, DSC and SEM analysis. The in vivo study report ensures the suitability of PEGylated dendrimer in connection to prolonged delivery of Rifampicin. Moreover, PEGylated system has shown a reduced hemolytic toxicity.
Conclusion: The observed results concluded that the PEGylated method was less time consuming, inexpensive, and reproducible, and it also reduces toxicity.
Keywords: PAMAM dendrimers, rifampicin, PEGylation, in vivo PAMAM dendrimers, anti-tubercular studies, hemolytic toxicity.
Current Drug Therapy
Title:Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers
Volume: 12 Issue: 2
Author(s): Pandurangan Dineshkumar, Theivendren Panneerselvam*, Kilim Deepti Brundavani, Kunjiappan Selvaraj and Palanirajan Vijayaraj Kumar
Affiliation:
- Department of Pharmaceutical Chemistry, Karavali College of Pharmacy, Vamanjoor, Mangaluru, Karnataka 575028,India
Keywords: PAMAM dendrimers, rifampicin, PEGylation, in vivo PAMAM dendrimers, anti-tubercular studies, hemolytic toxicity.
Abstract: Objective: The aim of present study is to develop and explore efficiency of 5.0G EDA PAMAM dendrimers as long-duration drug release carriers for the treatment of tuberculosis.
Method: Rifampicin (RIF) was selected as a major drug for incorporation into PAMAM dendrimers based on its anti-tubercular activity and hydrophobic nature. Further polyethylene glycol (PEGylated) PAMAM dendrimers were evaluated for their hemolytic toxicity and in vivo anti-tubercular studies. The 5.0G PAMAM dendrimers are prepared by using initiator core ethylene diamine and methyl acrylate. Furthermore, the PEGylation was done by polyethylene glycol 2000 using epichlorhydrin as a cross linking agent.
Result: The Rifampicin loaded PEGylated 5.0G PAMAM dendrimers were characterized by FTIR, NMR, DSC and SEM analysis. The in vivo study report ensures the suitability of PEGylated dendrimer in connection to prolonged delivery of Rifampicin. Moreover, PEGylated system has shown a reduced hemolytic toxicity.
Conclusion: The observed results concluded that the PEGylated method was less time consuming, inexpensive, and reproducible, and it also reduces toxicity.
Export Options
About this article
Cite this article as:
Dineshkumar Pandurangan, Panneerselvam Theivendren*, Brundavani Deepti Kilim , Selvaraj Kunjiappan and Kumar Vijayaraj Palanirajan, Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers, Current Drug Therapy 2017; 12 (2) . https://dx.doi.org/10.2174/157488550703160121191905
DOI https://dx.doi.org/10.2174/157488550703160121191905 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patents in Targets and Drugs for Unbalanced Cytokine and Chemokine Network Mediated Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Metabolism-based Drug-drug Interactions in Patients with Chronic Respiratory Diseases: A Review Focusing on Drugs Affecting the Respiratory System
Current Drug Metabolism Perspectives and Prospects on mRNA Vaccine Development for COVID-19
Current Medicinal Chemistry Drug-Induced Anemia and Other Red Cell Disorders: A Guide in the Age of Polypharmacy
Current Clinical Pharmacology Cosignaling Complexity Gets More Convoluted: The Emerging Importance of the B7-Like Butyrophilin Family of Immune Regulators
Current Immunology Reviews (Discontinued) Synthesis of Novel Azetidinone Derivatives as Antitubercular Agents
Letters in Drug Design & Discovery Supercritical Fluid Particle Design of DPI Formulations (Review)
Current Pharmaceutical Design Protective Effect of Algerian <i>Genista vepres</i> Pomel Plant Against Isoniazid and Rifampicin Induced Liver Injury in <i>Wistar Albino</i> Rats
Current Bioactive Compounds New Oxadiazole Derivatives: Synthesis and Appraisal of Their Potential as Antimicrobial Agents
Letters in Drug Design & Discovery An Update of the Published Reports on Biologics Use for Psoriasis and the Reimbursement Status in Asia-Pacific Region
Current Rheumatology Reviews Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report
Current Drug Safety Armed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
Letters in Drug Design & Discovery Preclinical Models of Multiple Sclerosis: Advantages and Limitations Towards Better Therapies
Current Medicinal Chemistry Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective
Current Medicinal Chemistry Understanding Recognition and Self-assembly in Biology using the Chemist´s Toolbox. Insight into Medicinal Chemistry
Current Topics in Medicinal Chemistry Pyridines and Imidazopyridines with Medicinal Significance
Current Topics in Medicinal Chemistry Adhatoda vasica Nees: Phytochemical and Pharmacological Profile
The Natural Products Journal Colloidal Drug Delivery Systems in Vaccine Delivery
Current Drug Targets Targeting Folate Metabolism in the Human Malaria Parasite Plasmodium falciparum
Current Enzyme Inhibition A Concise Overview on Recent Advances in Pharmaceutical Aerosols and their Commercial Applications
Current Materials Science